Management of Supraventricular Tachycardia with Hypokalemia

Immediate Hemodynamic Assessment and Intervention

If a patient with supraventricular tachycardia (SVT) is hemodynamically unstable, the American Heart Association recommends proceeding immediately to synchronized cardioversion at 50-100J without delay, as stated by the American College of Cardiology 1, 2
For hemodynamically stable patients, the American College of Cardiology suggests allowing time for potassium correction and stepwise pharmacologic intervention, as recommended by the American Heart Association 2, 3

The American Diabetes Association recommends delaying adenosine or other SVT treatment if serum potassium is <3.3 mEq/L to avoid life-threatening arrhythmias, cardiac arrest, or respiratory muscle weakness, with a strength of evidence based on expert opinion 4
According to the American Heart Association, administering 20-30 mEq potassium per liter of IV fluid (2/3 KCl and 1/3 KPO4) is recommended to maintain serum potassium 4-5 mEq/L, with a moderate strength of evidence 4

For hemodynamically stable patients, the American College of Cardiology recommends attempting vagal maneuvers first, such as the modified Valsalva maneuver, which has a 31-43% success rate, with a high strength of evidence 2, 3
If vagal maneuvers are unsuccessful, the American Heart Association suggests giving adenosine 6 mg rapid IV bolus through a proximal vein with immediate saline flush, which has a 90-95% success rate for AVNRT/AVRT, with a high strength of evidence 2, 3
Alternative agents, such as IV diltiazem or verapamil, have a 64-98% success rate, or IV beta-blockers if adenosine fails, as recommended by the American College of Cardiology, with a moderate strength of evidence 1, 5, 2
For hemodynamically unstable patients, the American Heart Association recommends synchronized cardioversion immediately, which has essentially a 100% success rate, with a high strength of evidence 1, 2, 3